History

Based on a novel method for the production of nanoporous frameworks discovered by Dr. Alfonso Garcia-Bennett, Nanologica was spun out from the Department of Structural Chemistry at Stockholm University in 2004. The materials have a very high surface area and the method for synthesis allowed control over their structural properties. Exciting potential applications included catalysis and pharmaceuticals. To commercialize this technology, Dr. Garcia-Bennett teamed up with Dr. Krim Talia.

The core business of Nanologica is the design, characterization and synthesis of nanoporous frameworks. Nanologica offers control over the design, composition and the functionalization of these materials, each giving specific properties to the particles. Essentially, by controlling these parameters Nanologica can give customized solutions for a wide range of industries such as catalysis, bio-separation, cosmetics, drug delivery, diagnostics, noise insulation, solar cells, stem cell research and food sciences.

Nanologica has an extensive IP portfolio, supporting the above-mentioned applications. It consists of a base patent on a method of producing these frameworks and the frameworks so produced, as well as relevant application patents. This portfolio has been developed over the years through joint research projects with partners from different industries.

For each application area, it is necessary to understand the market needs, customize the material properties to suit the industry, and then package and market the finished product(s). With many application areas, the challenge is to come out with innovative solutions to gather and optimize the use resources. To achieve this, Nanologica follows a spin out model. In this model, each time an application area is developed to a near finished product, a daughter company is spun out. Examples of these are NLAB Solar and NLAB Biosciences commercializing in the energy and pharmaceutical areas.